SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

10 Nov 2022 Evaluate
The Total revenue for the quarter ended September 2022 of  Rs. 3833.42 millions remain, more or less, the same.Net profit of the cmpany stood at Rs. 165.24 millions for the quarter ended September 2022 a decline of -52.00% from Rs. 344.28 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 279.58 millions from 488.03 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 3833.42 3693.88 3.78 6577.39 7346.19 -10.47 14492.67 11124.23 30.28
Other Income 8.74 119.74 -92.70 15.83 135.57 -88.32 102.35 117.74 -13.07
PBIDT 279.58 488.03 -42.71 422.76 930.29 -54.56 1393.72 1241.47 12.26
Interest 4.74 0.00 0.00 8.69 2.11 311.85 -73.66 17.88 -511.97
PBDT 274.84 488.03 -43.68 414.07 928.18 -55.39 1467.38 1223.59 19.92
Depreciation 44.64 57.01 -21.70 88.35 110.97 -20.38 211.95 281.10 -24.60
PBT 230.20 431.02 -46.59 325.72 817.21 -60.14 1255.43 942.49 33.20
TAX 64.96 86.74 -25.11 91.73 164.46 -44.22 244.81 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 24.83 0.00 0.00
PAT 165.24 344.28 -52.00 233.99 652.75 -64.15 1010.62 942.49 7.23
Equity 1022.27 899.59 13.64 1022.27 899.59 13.64 955.59 899.59 6.23
PBIDTM(%) 7.29 13.21 -44.80 6.43 12.66 -49.24 9.62 11.16 -13.83

Morepen Laboratories Share Price

41.92 0.79 (1.92%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×